Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
Aging · 2023
DOI: 10.18632/aging.204972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Hanrong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Extracorporeal Shock Wave Lithotripsy, Meizhou People’s Hospital (Huangtang Hospital), Meizhou 514031, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Urinary Bladder Neoplasms, Apoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Extracorporeal Shock Wave Lithotripsy, Meizhou People’s Hospital (Huangtang Hospital), Meizhou 514031, China.
- Department of Urology, Meizhou People’s Hospital (Huangtang Hospital), Meizhou 514031, China.
Zitieren
APA
Li, H., Jiang, H., Huang, Z., Chen, Z., & Chen, N. (2023). Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis. Aging. https://doi.org/10.18632/aging.204972
Vancouver
Li H, Jiang H, Huang Z, Chen Z, Chen N. Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis. Aging. 2023. doi:10.18632/aging.204972
BibTeX
@article{Li2023,
author = {Li, Hanrong and Jiang, Huiming and Huang, Zhicheng and Chen, Zhilin and Chen, Nanhui},
title = {Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204972}
}
EUVIMED